Schmidt Boris, Chun Kyoung Ryul Julian, Kuck Karl-Heinz, Ouyang Feifan
Hanseatisches Herzzentrum Hamburg, Asklepios Klinik St. Georg, Hamburg, Germany.
Herz. 2009 Nov;34(7):554-60. doi: 10.1007/s00059-009-3292-8.
Ventricular tachycardias (VT) associated with the His-Purkinje system may occur in patients with and without organic heart disease. The former may encounter bundle branch reentrant VT, a macroreentrant VT utilizing the specific conduction system. It frequently occurs in patients with preexisting conduction disturbance such as complete left bundle branch block and may be eliminated by catheter ablation of the right bundle branch. After successful ablation, patient's prognosis depends on the presence or absence of structural heart disease.In patients without structural heart disease, VT with right bundle branch block pattern and superior axis, referred to as idiopathic left ventricular tachycardia, is observed. It is a reentrant VT utilizing the posterior left fascicle and the Purkinje network. The two treatment options include antiarrhythmic drug therapy with verapamil or curative catheter ablation.Another form of ventricular arrhythmia originating in the Purkinje network is idiopathic ventricular fibrillation (IVF). Focal triggers from the right and left ventricular Purkinje network induce premature ventricular contractions inducing IVF. This is amenable to catheter ablation leading to a significant reduction in ICD (implantable cardioverter defibrillator) interventions in sudden cardiac death survivors.
与希氏-浦肯野系统相关的室性心动过速(VT)可发生于有或无器质性心脏病的患者。前者可能会出现束支折返性室性心动过速,这是一种利用特定传导系统的大折返性室性心动过速。它常发生于已有传导障碍(如完全性左束支传导阻滞)的患者,可通过导管消融右束支来消除。消融成功后,患者的预后取决于是否存在结构性心脏病。在无结构性心脏病的患者中,可观察到呈右束支传导阻滞图形且电轴向上的室性心动过速,称为特发性左室性心动过速。它是一种利用左后分支和浦肯野网络的折返性室性心动过速。两种治疗选择包括使用维拉帕米的抗心律失常药物治疗或根治性导管消融。另一种起源于浦肯野网络的室性心律失常形式是特发性心室颤动(IVF)。来自右心室和左心室浦肯野网络的局灶性触发因素诱发室性早搏,进而诱发特发性心室颤动。这适合进行导管消融,可显著减少心脏性猝死幸存者的植入式心脏复律除颤器(ICD)干预次数。